Table 2.
Experimental and predicted anti-proliferative activity of analogues derived from 2
SKBr3 (μM) | Predicted (μM) | MCF-7 (μM) | |
---|---|---|---|
16 | 1.41±0.20a | 0.99 | 1.58±0.09 |
17 | 1.40± 0.07 | 1.63 | 1.44± 0.05 |
18 | 1.40± 0.11 | 0.73 | 1.12± 0.16 |
19 | 0.60±0.01 | 0.58 | 1.25±0.39 |
20 | 3.46±0.02 | 1.74 | 5.01±0.01 |
21a | 2.26±0.12 | 2.00 | 2.00±0.18 |
21b | 1.67±0.20 | 1.42 | 1.62±0.04 |
21c | 1.68±0.12 | 1.83 | 2.10±0.08 |
21d | 11.5± 2.0 | 2.90 | 11.7±1.0 |
21e | 3.50±0.01 | 0.97 | 1.61±0.16 |
22a | 2.43±0.04 | 1.15 | 2.17±0.11 |
22b | 0.84±0.18 | 0.96 | 1.43±0.08 |
22e | 2.30±0.57 | 0.33 | 1.48±0.14 |
Values represent mean ± standard deviation for at least two separate experiments performed in triplicate.